Sagimet Biosciences Inc. (SGMT) Return on equity
Sagimet Biosciences Inc. (SGMT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-50.0%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -50.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SGMT financial trends
SGMT RevenueSGMT Net incomeSGMT Net marginSGMT Gross profitSGMT Gross marginSGMT Operating incomeSGMT Operating marginSGMT Operating cash flowSGMT Free cash flowSGMT Capital expendituresSGMT Stock buybacksSGMT Dividends paidSGMT Total assetsSGMT Total liabilitiesSGMT Shareholders’ equitySGMT overview →